Treatment outcomes and recurrence rates in patients with granulomatous mastitis undergoing lumpectomy and anti-tubercular therapy
Keywords:
Granulomatous mastitis, Lumpectomy, Anti-tubercular therapyAbstract
Background: Granulomatous mastitis (GM) is an uncommon, persistent inflammatory breast condition that can be difficult to diagnose and treat. It often looks like breast cancer. The goal of this study was to evaluate treatment outcomes and recurrence rates in GM patients undergoing anti-tubercular therapy (ATT) after a lumpectomy. Methods: A prospective observational study was conducted on 23 female GM patients at a tertiary care center. Clinical presentations, histological findings, and treatment outcomes following lumpectomy and Category 1 ATT were investigated during a one-year follow-up. Results: The mean age of patients was 33 ± 5 years,
with lump sizes ranging from 3 to 5 cm and average symptom duration of 3 months.
References
Wolfrum A, Kümmel S, Theuerkauf I, Pelz E, Reinisch M. Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge. Breast Care (Basel). 2018 Dec;13(6):413-418. doi: 10.1159/000495146
Bakaris S, Yuksel M, Ciragil P, Guven MA, Ezberci F, Bulbuloglu E. Granulomatous mastitis including breast tuberculosis and idiopathic lobular granulomatous mastitis. Can J Surg. 2006 Dec;49(6):427-30.
